Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010
by ikfe-CRO GmbH.
Recruitment status was Active, not recruiting
Study NCT01206647 Information provided by ikfe-CRO GmbH
First Received on September 15, 2010. Last Updated on September 21, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Metformin and Saxagliptin
Additional drug interventions recognized in this trial
Insulin
Metformin
Saxagliptin
More general drug interventions related to this trial
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
ikfe-CRO GmbH
AstraZeneca
IKFE Institute for Clinical Research and Development
Back to top of Main Content